Discover an oncology-focused company that gained confidence in their dose selection for an AML trial with pediatric patients and reduced their clinical development costs, by using mechanistic modeling.
Sutro is a clinical-stage company focused on the discovery and development of precisely designed cancer therapeutics. They have a large variety of potential therapeutics in their pipeline, including antibody-drug conjugates (ADC), bispecific antibodies, and cytokine-based therapeutics targeting immuno-oncology and autoimmune pathways.
Solutions
Therapeutic specialty
“Applied BioMath* was responsive, prompt, and effective. It was seamless to convene the appropriate members and skill sets to work together to problem solve for this important pediatric AML initiative.”
– Anne Borgman, CMO, Sutro Biopharma
“We were excited to make a direct impact on our client’s IND approval, and to support the clinical development of this molecule that can save the lives of young children.”
– Marissa Renardy, Principal Scientist, Modeling, Applied BioMath*
Contact us
